Hotline:400-820-3792

Inhibitors?ScreeningLibraries?Proteins

www.MedChemE

VAVVR(pT)PPK(pS)PSSAK-(Lys-13C6,15N2)TFA

Cat.No.:HY-173090S

分?式:C????C?H???N????N?O??P?.xC?HF?O?

Sequence:Val-Ala-Val-Val-Arg-{p-Thr}-Pro-Pro-Lys-{p-Ser}-Pro-Ser-Ser-A

la-{Lys-13C6,15N2}

SequenceShortening:VAVVR-{p-Thr}-PPK-{p-Thr}-PSSA-{Lys-13C6,15N2}

作?靶点:Isotope-LabeledCompounds

作?通路:Others

储存?式:Pleasestoretheproductundertherecommendedconditionsin

theCertificateofAnalysis.

BIOLOGICALACTIVITY

?物活性VAVVR(pT)PPK(pS)PSSAK-(Lys-13C6,15N2)TFA是带有13C标记和15N标记的VAVVR(pT)PPK(pS)PSSAK-

(Lys)TFA。

体外研究Stableheavyisotopesofhydrogen,carbon,andotherelementshavebeenincorporatedintodrugmolecules,

largelyastracersforquantitationduringthedrugdevelopmentprocess.Deuterationhasgainedattention

becauseofitspotentialtoaffectthepharmacokineticandmetabolicprofilesofdrugs.

McePdfHeight

Caution:Producthasnotbeenfullyvalidatedformedicalapplications.

Forresearchuseonly.

Tel:400-820-3792;021